Company news
Ligand Pharmaceuticals Incorporated news in 2019
Ligand Pharmaceuticals Incorporated's news releases, calls and decks from 2019, newest first.
Two Ligand Pharmaceuticals Board Members Recognized as 2019 Most Influential Corporate Directors by WomenInc. Magazine
December 22, 2019
Ligand Enters into Worldwide OmniAb® Platform License Agreement with Sanofi
December 1, 2019
Ligand Pharmaceuticals Ranked in Deloitte’s 2019 Technology Fast 500™
November 11, 2019
Ligand Presents Positive Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol
November 7, 2019
Ligand to Participate in the Stephens 2019 Nashville Investment Conference
November 6, 2019
Ligand Reports Third Quarter 2019 Financial Results
November 4, 2019
Ligand to Report Third Quarter 2019 Results on November 5th
October 21, 2019
Ligand Appoints Pharmaceutical Executive Sarah Boyce to its Board of Directors
October 14, 2019
Ligand and SQ Innovation Enter into Exclusive Worldwide Captisol® License and Supply Agreements for High-Concentration Furosemide Formulation
July 7, 2019
Decks in 2019
- Investor Day (March 2019)
Investor day · 200 slides · Mar 12, 2019
- Merger or Acquisition (March 2019)
Merger or acquisition · 25 slides · Mar 5, 2019